SCHEMBL5758845

SCHEMBL5758845

O=C(c1cccc([N+](=O)[O-])c1)N1CCC(Cl)CC1

nearest known ligand 0.74

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 1/20 0.74
RXFP1 Q9HBX9 1/20 0.72
HSD11B1 P28845 1/20 0.70
KDM4E B2RXH2 1/20 0.69
ALDH1A1 P00352 5/20 0.64
LMNA P02545 2/20 0.64
SMN1; SMN2 Q16637 2/20 0.64
HTT P42858 2/20 0.64
KMT2A Q03164 2/20 0.62
CA12 O43570 1/20 0.62
CA1 P00915 1/20 0.62
CA2 P00918 1/20 0.62
CA7 P43166 1/20 0.62
CA9 Q16790 1/20 0.62
CA14 Q9ULX7 1/20 0.62
MAPT P10636 2/20 0.59
MAPK1 P28482 1/20 0.59
TSHR P16473 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15271592 0.89 RXFP1 (0.72) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL6209378 0.87 MGLL (0.83) MGLLRXFP1HSD11B1KDM4EKMT2A
SCHEMBL1879807 0.85 RXFP1 (0.91) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL15271998 0.84 RXFP1 (0.74) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL14894861 0.84 RXFP1 (0.65) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL3086635 0.83 RXFP1 (0.81) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL655882 0.82 KMT2A (0.70) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL520435 0.82 KDM4E (1.00) MGLLRXFP1KDM4EALDH1A1LMNA
SCHEMBL3093675 0.82 RXFP1 (0.79) MGLLRXFP1HSD11B1KDM4EALDH1A1
SCHEMBL15272028 0.82 RXFP1 (0.74) MGLLRXFP1HSD11B1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1428534-B1 BENZOFURAZAN DERIVATIVES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES UNIV CALIFORNIA (US) 2006-05-17 EP disclosed
EP-1428534-A1 BENZOFURAZAN DERIVATIVES FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES The Regents of the University of California (US) 2004-06-16 EP disclosed
EP-0960105-B1 BENZOFURAZAN COMPOUNDS THAT ENHANCE AMPA RECEPTOR ACTIVITY UNIV CALIFORNIA (US) 2004-05-12 EP disclosed
US-6313115-B1 ALLEVIATE IMPAIRMENT OF MEMORY, OR OTHER COGNITIVE FUNCTIONS CAUSED BY HYPOGLUTAMATERGIC CONDITION OR BY DEFICIENCY IN NUMBER OR STRENGTH OF EXCITATORY SYNAPSES OR IN NUMBER OF AMPA RECEPTORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-11-06 US disclosed
EP-0960105-A1 BENZOFURAZAN COMPOUNDS WHICH ENHANCE AMPA RECEPTOR ACTIVITY The Regents of the University of California (US) 1999-12-01 EP disclosed
WO-1998035950-A1 BENZOFURAZAN COMPOUNDS WHICH ENHANCE AMPA RECEPTOR ACTIVITY CORTEX PHARMACEUTICALS, INC. (US) 1998-08-20 WO disclosed